Distribution of serum erythropoietin levels in Japanese patients with myelodysplastic syndromes.

Distribution of serum erythropoietin levels in Japanese patients with myelodysplastic syndromes. - Serum erythropoietin levels in Japanese patients with MDS

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000022394

Enrollment

Registered

2016-05-20

Start date

2011-04-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myelodysplastic syndromes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with MDS who are treated in Jichi Medical University Hospital. All subtypes of MDS are eligible.

Exclusion criteria

Exclusion criteria: Patients who are treated with erythropoiesis stimulating agents. Patients from whom informed consent cannot be obtained.

Design outcomes

Primary

Measure	Time frame
Serum erythropoietin (EPO) levels	—

Secondary

Measure	Time frame
Factors that correlate with serum EPO levels hemoglobin, hematocrit etc.	—

Countries

Japan

Contacts

Public ContactTakahiro Suzuki

Jichi Medical University Division of Hematology, Department of Medicine

tasuzuki@jichi.ac.jp0285-58-7353

Outcome results